Concepedia

Sarah L. Demmon

SL

2

Publications

101

Citations

2

H-Index

2020

Active since

Affiliations

Eli Lilly (United States)(Current)

Sarah L. Demmon is an author at Eli Lilly (United States) specializing in immunotherapy, reliability, and immunology.

Top concepts

Publications per year

2020–2022

2

Publications

2

Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19

Michael Dougan, Masoud Azizad, Peter Chen et al. · 2022 · 75 citations · Full text

, , +12

A cross-industry forum on benchmarking critical quality attribute identification and linkage to process characterization studies

Sarah L. Demmon, Swapnil Bhargava, Doreen Ciolek et al. · Biologicals · 2020 · 26 citations · Full text

, , +20

Rows per page

1–2 of 2